Soligenix begins confirmatory phase 3 trial of HyBryte for treatment of cutaneous T-cell lymphoma: Princeton, New Jersey Wednesday, December 18, 2024, 14:00 Hrs [IST] Soligenix, I ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

A national survey highlighted scars, acne, and hyperhidrosis as the most commonly treated pediatric cosmetic conditions, with ...

U.S. FDA approved Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the treatment of inflammatory lesions of rosacea ... Corporation (Nasdaq: DERM) (“Journey Medical ...

Screenings. A board-certified dermatologist travels to the fire station to provide free skin cancer screenings through the ...

The following is a summary of “How dermatologic surgeons decide to proceed with surgery for nonmelanoma skin cancer when site ...

A monoclonal antibody that targets interleukin (IL)-31 receptor alpha, nemolizumab is specifically indicated for individuals ...

Skin cancers are the most common cancer worldwide,1 and early diagnosis is associated with better outcomes.2 There is ...

What is geriatric dermatology? It is described by the AAD’s Geriatric Dermatology ERG of the AAD as “an emerging subspecialty ...

Researchers at The University of Sydney have identified a significant increase in melanoma-related death risk for patients ...

Meghan Solc, DVM, DACVD, shares common dos and don'ts when it comes to the itchy client in your clinic, plus how to ...